BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Valproic acid, rs2476601, PPARA, Metabolism of xenobiotics, Leukemia, Intestine)
Bookmark Forward

QuickView for ribonuclease inhibitor activity (biogroup)


Body Atlas

Most Correlated Tissues

  1. Peritoneum
  2. Cecum
  3. Fetal brain
  4. Jejunum
  5. Duodenum
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Injury of eye region
  2. Disorder related to transplantation
  3. Urogenital injury
  4. Disorder of cornea
  5. Huntington's disease
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. TNF-Related Apoptosis-Inducing Ligand
  2. stearic acid
  3. GSK690693
  4. N-palmitoyl-S-(2,3-bis(palmitoyloxy)propyl)cysteinyl-seryl-lysyl-lysyl-lysyl-lysine
  5. N-(2-aminophenyl)-4-((4-pyridin-3-ylpyrimidin-2-ylamino)methyl)benzamide
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. SMYD2
  2. CPSF3
  3. RNH1
  4. CYP2C19
  5. DEAF1
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
  2. L1000 CMAP - Non-small cell lung cancer A549.311 cells with CRISPR targeted gene knockouts
  3. Human primary breast cancer tissue before treatment with gemcitabine, epirubicine and docetaxel
  4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
  5. L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Role of ribonuclease and ribonuclease inhibitor activities in Alzheimer's disease.
  2. Developmental and regional variations in ribonuclease inhibitor activity in brain.
  3. Effect of detergents upon ribonuclease inhibitor activity.
  4. Ribonuclease and ribonuclease inhibitor activity in the uteri of immature rats.
  5. Specificity of the natural rat liver ribonuclease inhibitor towards nuclease activities of subcellul…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Inflammation Regulation in Obese Patients
  2. Tislelizumab in Combination With Anlotinib With ES-SCLC as Maintenance Therapy After First Line Chem…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.